More

• USPS Takes Armstrong to Court  Friday, 22 Feb 2013 | 1:41 PM ET

  

  CNBC's Brian Shactman reports the Department of Justice is joining Floyd Landis in a lawsuit accusing Lance Armstrong using performance-enhancing drugs while being sponsored by the U.S. Postal Service. Armstrong says he did not cost the government money. Instead, he says the Postal Service actually benefitted to the tune of more than $100 million from its association with the disgraced cyclist.

• Global Fight Against Tuberculosis  Friday, 22 Feb 2013 | 1:22 PM ET

  

  Turberculosis is making a global comeback, including in the United States. Dr. William Schaffner of Vanderbilt University School of Medicine, discusses the concern surrounding the disease.

• Higher Taxes Put the Brakes on Retail Spending Wednesday, 13 Feb 2013 | 8:33 AM ET

  

  Retail sales barely rose in January as tax increases and higher gasoline prices restrained spending. Separately, import and export prices rose slightly less than expected in the month.

• UPDATE 2-CVS Caremark profit up, buys Brazil's Onofre chain Wednesday, 6 Feb 2013 | 10:15 AM ET

  Feb 6- CVS Caremark Corp posted a bigger-than-anticipated rise in fourth-quarter profit on Wednesday, helped by growth at both its pharmacy services business and its CVS drugstore chain, and made its first international push by buying a Brazilian retailer.

• UPDATE 1-CVS buys Brazil's Drogaria Onofre in first international deal Wednesday, 6 Feb 2013 | 8:39 AM ET

  Feb 6- CVS Caremark Corp bought Drogaria Onofre, Brazil's 8th- largest drugstore chain, last week, marking the first time the drugstore and pharmacy services company has reached outside the United States, Chief Executive Larry Merlo said on Wednesday.

• UPDATE 1-CVS Caremark profit up on gains in both divisions Wednesday, 6 Feb 2013 | 7:51 AM ET

  Feb 6- CVS Caremark Corp posted a bigger-than-anticipated rise in fourth-quarter profit on Wednesday, helped by growth at both its pharmacy services business and its CVS drugstore chain. CVS Caremark was formed when drugstore chain CVS bought the Caremark pharmacy benefits management business in 2007 in a $27 billion stock deal.

• CVS Caremark profit up on gains in both divisions Wednesday, 6 Feb 2013 | 7:08 AM ET

  Feb 6- CVS Caremark Corp posted higher quarterly profit on Wednesday, helped by growth at both its pharmacy services business and its CVS drugstore chain. CVS earned $1.13 billion, or 90 cents per share, up from $1.06 billion, or 81 cents per share, a year earlier. Revenue rose 10.9 percent to $31.39 billion.

• Help Wanted: Washington Weed Czar  Wednesday, 30 Jan 2013 | 1:49 PM ET

  

  Washington State's liquor control board is seeking a marijuana consultant to help forge ahead regulation for its newly legalized substance. Steve Fox, director of government relations with the Marijuana Policy Project, offers insight.

• Opko Health CEO on Cytochromas Acquisition  Monday, 28 Jan 2013 | 6:15 PM ET

  

  Opko Health chairman and CEO Dr. Phillip Frost, offers insight on his company's acquisition of Cytochromas, its partnerships with companies like Bristol-Meyers Squibb, and where the company is headed this year.

• Actavis CEO: Continue Seeking Opportunities In Emerging Markets  Thursday, 24 Jan 2013 | 3:39 PM ET

  

  Watson Pharmaceuticals has merged with Actavis, and will now trade on the NYSE under ticker symbol ACT. Its president & CEO Paul Bisaro, discusses the U.S. economy and the generic drug industry.

• Branding & Redemption  Thursday, 17 Jan 2013 | 1:30 PM ET

  

  The world is gearing up for Lance Armstrong's big interview tonight with Oprah Winfrey. Robbie Vorhaus, founder & CEO of Vorhaus Communications, weighs in.

• Talking Numbers: Drug War Heats Up  Tuesday, 15 Jan 2013 | 3:30 PM ET

  

  The relative prospects for shares of Pfizer and Johnson & Johnson are debated by a fundamental analyst and a technical analyst. (2:58)

• CVS Changes the Way It Stocks Tylenol  Tuesday, 15 Jan 2013 | 2:46 PM ET

  

  In the wake of Johnson & Johnson's manufacturing problems, CVS has changed the way it stocks Tylenol, reports CNBC's Bertha Coombs.

• Lance Armstrong Confesses  Tuesday, 15 Jan 2013 | 1:44 PM ET

  

  NBC's Anne Thompson reports Lance Armstrong confessed to using performance enhancing drugs in an interview with Oprah Winfrey; and CNBC's Scott Cohn reports Armstrong has now complied with the subpoena for all of his medical records.

• Breakthrough Watch: MS Drug Could Have Other Uses Wednesday, 9 Jan 2013 | 6:17 PM ET

  

  Could a widely used MS treatment work on other diseases?

• BioMarin's CEO On Its Product Pipeline  Tuesday, 8 Jan 2013 | 2:20 PM ET

  

  The iShare Biotech ETF is up 32 percent over the past year. Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, discusses the reason behind his company behind up 24.9 percent in the last 3 months.

• Death of Gift Cards? Tuesday, 8 Jan 2013 | 2:09 PM ET

  

  Retailers should be buzzing right now with holiday gift card redemptions. But, there's early evidence retailers aren't getting much of a boost from gift cards this year, according to NBG Market Analyst Brian Sozzi.

• Onyx CEO on Partnership With Bayer  Tuesday, 8 Jan 2013 | 1:22 PM ET

  

  Onyx Pharmaceuticals CEO Dr. Anthony Coles discusses his company's thyroid cancer drug and its blood cancer drug and its partnership with Bayer.

• NPS Pharmaceuticals CEO on Gattex's FDA Approval  Monday, 7 Jan 2013 | 6:15 PM ET

  

  NPS Pharmaceuticals CEO Dr. Francois Nader discusses the approval of its short bowel syndrome drug Gattex, and what's next for the company.

• Retail Sales Winners & Losers Thursday, 3 Jan 2013 | 12:27 PM ET

  

  The latest batch of retail sales reports shed light on who the retail winners are right now.